Form Type: 4

SEC EDGAR Link
Accession Number:0000899243-16-029936
Date:2016-09-21
Issuer: BIODELIVERY SCIENCES INTERNATIONAL INC (BDSI)
Original Submission Date:

Reporting Person:

VASISHT NIRAJ
C/O BIODELIVERY SCIENCES INTL, INC.,
4131 PARKLAKE AVENUE, SUITE 225 RALEIGH, NC 27612

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2016-09-21 A 4,661 a $0.00 73,081 direct
COMMON STOCK 2016-09-21 M 27,666 a $0.00 100,747 direct
COMMON STOCK 2016-09-21 M 16,667 a $0.00 117,414 direct
COMMON STOCK 2016-09-21 M 24,980 a $0.00 142,394 direct
COMMON STOCK 2016-09-21 M 66,667 a $0.00 209,061 direct
COMMON STOCK 2016-09-21 S 40,000 d $2.39 169,061 direct
COMMON STOCK 2016-09-23 S 7,000 d $2.68 162,061 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
RESTRICTED STOCK UNITS 0.0 2016-09-21 deemed execution date M 27,666 (d) 2016-02-20 2016-09-21 common stock 27,666 $0.00 0 direct
RESTRICTED STOCK UNITS 0.0 2016-09-21 deemed execution date M 16,667 (d) 2016-01-30 2017-01-30 common stock 16,667 $0.00 16,666 direct
RESTRICTED STOCK UNITS 0.0 2016-09-21 deemed execution date M 24,980 (d) 2016-02-22 2017-02-22 common stock 24,980 $0.00 24,980 direct
RESTRICTED STOCK UNITS 0.0 2016-09-21 deemed execution date M 66,667 (d) 2016-02-23 2018-02-23 common stock 66,667 $0.00 133,333 direct
Footnotes
IDfootnote
f1 the shares of common stock reported on this form 4 were acquired by the reporting person in connection with the vesting of restricted stock units ("rsus") granted to the reporting person under the issuer's long term incentive plan. pursuant to a deferral, these rsus vested on september 21, 2016.
f2 the shares of common stock were acquired by the reporting person as a result of the vesting of 27,666 rsus granted to the reporting person on february 20, 2013 under the issuer's 2011 equity incentive plan, as amended (the "plan"). pursuant to a deferral, these rsus vested on september 21, 2016.
f3 the shares of common stock were acquired by the reporting person as a result of the vesting of one-half of the rsus granted to the reporting person on january 30, 2014 under the plan. pursuant to a deferral, these rsus vested on september 21, 2016. the remaining half of the rsus under this grant will vest on january 30, 2017.
f4 the shares of common stock were acquired by the reporting person as a result of the vesting of one-half of the rsus granted to the reporting person on february 22, 2014 under the plan. pursuant to a deferral, these rsus vested on september 21, 2016. the remaining half of the rsus under this grant will vest on february 22, 2017.
f5 the shares of common stock were acquired by the reporting person as a result of the vesting of one-third of the rsus granted to the reporting person on february 23, 2015 under the plan. pursuant to a deferral, these rsus vested on september 21, 2016. the remainder of the rsus under this grant will vest in equal portions on each of (i) february 23, 2017 and (ii) february 23, 2018.
f6 the shares of common stock were sold under a pre-planned 10b5-1 trading plan and were sold to cover the reporting person's tax liability upon the vesting of rsus.
f7 on september 21, 2016, the reporting person sold an aggregate of 40,000 shares of the issuer's common stock at a weighted average price of $2.39 per share. the highest sale price for the common stock was $2.45 per share and the lowest sale price was $2.35 per share. the reporting person undertakes to provide the company, any security holder of the company or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
f8 the shares of common stock were sold upon expiration of a pre-planned 10b5-1 trading plan, and were sold to cover the reporting person's additional tax liability upon the vesting of rsus.
f9 on september 23, 2016, the reporting person sold an aggregate of 7,000 shares of the issuer's common stock at a weighted average price of $2.68 per share. the highest sale price for the common stock was $2.81 per share and the lowest sale price was $2.58 per share. the reporting person undertakes to provide the company, any security holder of the company or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
WhaleWisdom Logo

Elevate your investments